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Effect of short chain fatty acids on the expression of free fatty
acid receptor 2 (Ffar2), Ffar3 and early-stage adipogenesis
G Frost1,2, Z Cai2, M Raven2, DT Otway2, R Mushtaq2 and JD Johnston2
Adipose tissue has a major inﬂuence on insulin sensitivity. Stimulation of free fatty acid receptor 2 (FFAR2) has been proposed to
inﬂuence adipocyte differentiation. We hypothesised that exposing preadipocytes to short chain fatty acids would induce earlier
expression of nuclear receptors that co-ordinate adipogenesis, triglyceride accumulation and leptin secretion. 3T3-L1 preadipocytes
were differentiated in the presence of 1 μM acetate, 0.1–10 μM propionate or vehicle control. In experiment 1, expression of Ffar2 and
nuclear receptor mRNA was measured by quantitative PCR over 48 h following onset of differentiation. In experiment 2, extracellular
leptin concentration and intracellular triglyceride content were measured at days 0, 2, 4, 6, 8 and 10 following the onset of
differentiation. Control cells exhibited similar temporal dynamics of gene expression, triglyceride accumulation and leptin secretion as
reported previously. We were unable to detect expression of Ffar3mRNA at any stage of differentiation. Consistent with a lack of Ffar2
expression in the ﬁrst 24 h of differentiation, acetate and propionate had no signiﬁcant effect on nuclear receptor expression.
Furthermore, acetate or propionate treatment did not alter leptin concentration or triglyceride content. In conclusion, we observed no
signiﬁcant effect of propionate or acetate on adipogenesis in 3T3-L1 cells using validated quantitative techniques.
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INTRODUCTION
Adipose tissue has a major inﬂuence over the risk of developing
type 2 diabetes. Its dysregulation is thought to lie at the centre of
many metabolic abnormalities.1 The ability of preadipocytes to
differentiate into mature adipocytes has a signiﬁcant impact on
insulin resistance.2 Limited numbers of adipocytes in a hyperca-
loric environment leads to hypertrophic morphology and ectopic
lipid deposition in the liver, muscle and pancreas, which decreases
insulin sensitivity. A better understanding of adipogenesis is
therefore important for the maintenance of metabolic health.
Diets high in fermentable carbohydrate, which escapes
digestion in the small intestine and is fermented to short-chain
fatty acids (SCFA) in the colon, lead to a decrease in adiposity.3,4 In
humans, diets high in fermentable carbohydrate also improve
insulin-stimulated glucose uptake into adipocytes.5 The free fatty
acid receptor 2 (FFAR2; previously called GPCR43) is a G protein-
coupled receptor that has been shown to be activated by SCFA.6
More recently, free fatty acid release has been shown to be
reduced by SCFA in wild type, but not in FFAR2 knockout mice,
suggesting that FFAR2 expression is necessary for at least some of
the biological effects of SCFA.7 We and the others have
demonstrated that fermentable carbohydrates, which raise plasma
SCFA, affect adipocyte size and function.4,5 Furthermore, work by
Hong et al.8 has suggested that stimulation of FFAR2 with low
doses of SCFA may increase adipocyte differentiation in vitro.
If SCFA stimulate differentiation through the FFAR2 receptor,
exposure of preadipocytes to SCFA may regulate molecular
pathways considered to be key to cell differentiation.
We hypothesised that FFAR2 is expressed early after the
induction of 3T3-L1 cell differentiation and that addition of SCFA
inﬂuences the expression of nuclear receptors present during
differentiation, affecting both the lipid content and the secretion
of leptin. We tested this hypothesis using validated quantitative
and qualitative techniques.
MATERIALS AND METHODS
Cell culture
3T3-L1 preadipocytes (ATCC, LGC Standards, Teddington,
Middlesex, UK) were cultured in growth medium (Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen Ltd, Paisley, UK) supplemented
with 10% fetal bovine serum (Invitrogen), antibiotic/antimycotic
(Invitrogen) and sodium pyruvate (Sigma-Aldrich Co Ltd, Poole,
Dorset, UK)). For experiments, 3T3-L1 preadipocytes were seeded
into six-well plates. Two days postconﬂuence (day 0), growth
medium was changed to differentiation medium (growth medium
containing 0.5 mM IBMX (Sigma-Aldrich), 1 μM dexamethasone
(Sigma-Aldrich) and 10 μgml− 1 insulin (Invitrogen)). In both
experiments 1 and 2, cells were exposed to SCFA (acetate or
propionate at the speciﬁed concentrations) or vehicle control
during the entire differentiation process. A previous study
reported effects of 0.1 μM acetate and propionate on markers of
adipogenesis.8 Based on this study and our preliminary data of
cAMP inhibition (not shown), we chose to use 1 μM as the SCFA
concentration for our main experiments.
Experiment 1
To characterise molecular changes during early differentiation
events, cells were harvested in TRIzol (Invitrogen) at 0.5, 1, 2, 4, 8,
16, 24 and 48 h following the addition of the differentiation
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medium. Gene expression was measured by Taqman quantitative
real-time PCR (qPCR). In this experiment, SCFA were used at 1 μM
ﬁnal concentration.
Experiment 2
After 48 h in differentiation medium, cells were incubated in
growth medium containing 10 μgml− 1 insulin. Forty-eight hours
later, this was exchanged for normal growth medium, which was
replaced every 2 days thereafter. At days 0, 2, 4, 6, 8 and 10,
culture medium was collected for analysis of leptin concentration,
and cell lysates were prepared for quantitative analysis of
intracellular triglyceride content. For leptin and quantiﬁed
intracellular triglyceride measurement, SCFA were used at a ﬁnal
concentration of 1 μM. The experimental protocol was then
repeated for qualitative measurement of intracellular triglyceride
content by oil red O stain. As acetate and propionate have been
shown to be equally effective at stimulating adipogenesis in the
past,8 propionate was used at 0.1–10 μM ﬁnal concentration.
qPCR
To explore the impact of SCFA on early stages of adipocyte
differentiation, we chose nuclear receptors expressed early
(neuron-derived orphan receptor 1 (NOR-1) and nerve growth
factor-induced gene B (NGFI-B)), late (liver X receptor alpha (LXRα))
and throughout differentiation (glucocorticoid receptor (GR) and
retinoid X receptor alpha (RXRα)) as deﬁned previously,9 as well as
the SCFA receptors FFAR2 and FFAR3 (previously called GPCR41).
Total RNA was reverse transcribed using random primers and
M-MLV Reverse Transcriptase (Promega Corporation, Southampton,
UK). The resulting cDNA was then used for qPCR using
ABsolute QPCR ROX Mix (Abgene, Epsom, UK), as described
previously.10
Leptin assays
Leptin concentration in culture medium was measured using
Quantikine ELISA kits (R&D Systems Europe Ltd, Abingdon, UK)10
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Figure 1. Ffar2 and nuclear receptor mRNA expression during 3T3-L1 cell adipogenesis. The expression of Ffar2 and nuclear factors at 0.5, 1, 2,
4, 8, 16, 24 and 48 h following the induction of differentiation in 3T3-L1 preadipocytes with acetate (vertical lines), propionate (horizontal
lines) or vehicle control (hatched bars) added to the media. There was no signiﬁcant (P40.05, two-way ANOVA) effect of treatment or
time× treatment interaction for any of the genes measured.
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and normalised to total cellular protein, measured using a Pierce
BCA Protein Assay Kit (Thermo Fisher Scientiﬁc, Cramlington, UK).
Quantitative triglyceride analysis
Cells were rinsed twice with 1 × phosphate-buffered saline,
scraped into 0.1 M sodium dodecyl sulfate solution in 1 ×
phosphate-buffered saline and lysed by vortex mixing and
sonication. Triglyceride was measured using an Alfa Wassermann
triglyceride assay (Randox Laboratories Ltd, Crumlin, UK). Trigly-
ceride content was normalised to total cellular protein and
measured using a Pierce BCA Protein Assay Kit (Thermo Fisher
Scientiﬁc).10
Oil red O stain
Cells were stained for qualitative assessment of triglyceride
content as described previously.10
Statistical analysis
Quantitative gene expression data represent the mean ± s.e.m. of
n= 4 groups of cells from a representative experiment. Intracel-
lular triglyceride and secreted leptin data are pooled from n= 4
separate experiments. These data were analysed by two-way
analysis of variance (ANOVA) with Bonferoni’s post hoc analysis.
RESULTS
Expression of Ffar2 was only observed 48 h after the onset of
differentiation (Figure 1a). Overall, there was a signiﬁcant
(Po0.001, two-way ANOVA) effect of time on Ffar2 expression
but no signiﬁcant (P40.05, two-way ANOVA) effect of treatment
or time× treatment interaction. We could not detect Ffar3 mRNA
at any stage of adipogenesis in any of the treatment groups. There
was no signiﬁcant (P40.05, two-way ANOVA) effect of time,
treatment or time × treatment interaction on the expression of
Rxrα (Figure 1f). For all other nuclear receptor genes, there was a
signiﬁcant (Po0.001, two-way ANOVA) effect of time on
expression but no signiﬁcant (P40.05, two-way ANOVA) effect
of treatment or time × treatment interaction.
There was a signiﬁcant (Po0.001, two-way ANOVA) effect of
time on intracellular triglyceride content (Figure 2a) and extra-
cellular leptin concentration (Figure 2b). However, there was no
signiﬁcant (P40.05, two-way ANOVA) effect of treatment or
time× treatment interaction on either of these factors. Oil red O
staining allowed further assessment of intracellular triglyceride
content and qualitative analysis of cellular morphology. Because
of the lack of effect of acetate and propionate above, we used a
range of concentrations, from 0.1 to 10 μM. However, none of the
treatment groups exhibited a detectable change in oil red O
staining or cell morphology with propionate (Figure 2c).
DISCUSSION
Insulin sensitivity deteriorates with increased ectopic fat deposi-
tion in the liver, muscle and pancreas.2 This may be due to limited
numbers of hypertrophic adipocytes unable to store the lipid
effectively in a hypercaloric environment.2 Understanding factors
that effect adipocyte differentiation may therefore improve
metabolic ﬂexibility.
Recent evidence has demonstrated that stimulation of FFAR2
with the SCFA acetate and propionate causes a reduction in free
fatty acid release from the adipocyte, and this effect is lost in
tissue from the Ffar2 knockout mouse.7 Using 3T3-L1 cells, it has
been suggested that exposure of adipocytes to low concentra-
tions of acetate and propionate increases differentiation and
intracellular lipid content.8 Our initial aim was to extend this work
by testing the hypothesis that SCFA would inﬂuence the
expression of nuclear receptors present during differentiation.
Here we have shown in 3T3-L1 cells that Ffar2 mRNA is not
expressed until approximately 48 h into the differentiation
process. Exposing preadipocytes to either propionate or acetate
from the induction of differentiation made no difference to the
time to expression of Ffar2 mRNA over the time course studied.
We were unable to detect Ffar3, consistent with other published
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Figure 2. Triglyceride accumulation and leptin secretion during 3T3-
L1 cell adipogenesis. (a) The lipid content and (b) leptin output of
3T3-L1 cells following induction of differentiation of 3T3-L1
preadipocytes at days 0, 2, 4, 6, 8 and 10 with acetate (horizontal
lines), propionate (white) or control (black) added to the media.
There was no signiﬁcant (P40.05, two-way ANOVA) effect of
treatment or time× treatment interaction for either of the para-
meters measured. (c) Oil red O staining following induction of
differentiation of 3T3-L1 preadipocytes at days 0, 2, 4, 6, 8 and 10
with propionate.
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data.8 We measured mRNA of ﬁve nuclear receptors that are
implicated in adipogenesis and reported to be expressed early
(NOR-1 and NGFI-B), late (LXRα) and throughout differentiation
(RXRα and GR).9 Control groups exhibited similar patterns of
expression of these genes over 48 h as previously reported.9
However, consistent with the lack of effect of acetate or
propionate on the timing of onset of Ffar2 expression, we were
unable to demonstrate an effect of SCFA on nuclear receptor
expression at any stage within the initial 48 h of differentiation.
These data imply that at low physiological concentrations SCFA
are unable to regulate key molecular events of adipogenesis
without the expression of Ffar2 or Ffar3.
Given the lack of effect on established molecular markers of
early adipogenesis, we then examined the effects of SCFA on
physiological changes. In contrast to the data of Hong et al.,8 using
a 10 times higher concentration, we failed to observe a signiﬁcant
effect of SCFA on intracellular triglyceride content and leptin
secretion occurring after the onset of Ffar2 mRNA expression.
Moreover, using a range of 0.1–10 μM propionate, we were unable
to observe any changes in oil red O staining or gross cellular
morphology.
In conclusion, our data do not support a major role for SCFA in
adipogenesis of 3T3-L1 cells.
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